Investigating Preoperative Hematologic Markers for Prediction of Ovarian Cancer Surgical Outcome |
Ashrafganjoei, Tahereh
(Gyneco-Oncology, Preventative Gynecology Research Center (PGRC). Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences)
Mohamadianamiri, Mahdiss (Gyneco-Oncology, Preventative Gynecology Research Center (PGRC). Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences) Farzaneh, Farah (Gyneco-Oncology, Preventative Gynecology Research Center (PGRC). Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences) Hosseini, Maryam Sadat (Gyneco-Oncology, Preventative Gynecology Research Center (PGRC). Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences) Arab, Maliheh (Gyneco-Oncology, Preventative Gynecology Research Center (PGRC). Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences) |
1 | Asher V, Lee J, Innamaa A, et al (2011). Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol, 13, 499-503. DOI |
2 | Bhatti I, Peacock O, Lloyd G, et al (2010). Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg, 200, 197-203. DOI |
3 | Cho H, Hur HW, Kim SW, et al (2009). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23. DOI |
4 | Clarke-Pearson DL (2009). Clinical practice. Screening for ovarian cancer. N Engl J Med, 361, 170-7. DOI |
5 | Fader AN, Rose PG (2007). Role of surgery in ovarian carcinoma. J Clin Oncol, 25, 2873-83. DOI |
6 | Fathalla MF (1972). Factors in the causation and incidence of ovarian cancer. Obstet Gynecol Surv, 27, 751-68. DOI |
7 | Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300. DOI |
8 | Kodama S, Tanaka K, Tokunaga A, et al (1997). Multivariate analysis of prognostic factors in patients with ovarian cancer stage I and II. Int J Gynaecol Obstet, 56, 147-53. DOI |
9 | Kokcu A, Kurtoglu E, Celik H, et al (2014). May the platelet to lymphocyte ratio be a prognostic factor for epithelial ovarian cancer? Asian Pac J Cancer Prev, 15, 9781-4. DOI |
10 | Levin J, Conley CL (1964). Thrombocytosis Associated with Malignant Disease. Arch Intern Med, 114, 497-500. DOI |
11 | Li AJ, Madden AC, Cass I, et al (2004). The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol, 92, 211-4. DOI |
12 | Markman M, Bundy BN, Alberts DS, et al (2001). Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the gynecologic oncology group, southwestern oncology group, and eastern cooperative oncology group. J Clin Oncol, 19, 1001-7. DOI |
13 | Milne K, Alexander C, Webb JR, et al (2012). Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes. J Transl Med, 10, 33. DOI |
14 | Rochet NM, Markovic SN, Porrata LF (2012). The role of complete blood cell count in prognosisa watch this space! Oncol Hematology Review, 8, 76-82. DOI |
15 | Siegel RL, Miller KD, Jemal A (2015). Cancer statistics, 2015. CA Cancer J Clin, 65, 5-29. DOI |
16 | Smith RA, Ghaneh P, Sutton R, et al (2008). Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg, 12, 1422-8. DOI |
17 | Soonthornthum T, Suraseraneewong V, Kengsakol K, et al (2007). Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thai, 90, 1495-500. |
18 | Templeton AJ, McNamara MG, Seruga B, et al (2014). Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst, 106, 124. DOI |
19 | Thavaramara T, Phaloprakarn C, Tangjitgamol S, et al (2011). Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. J Med Assoc Thai, 94, 871-7. |
20 | Vergote IB, Kaern J, Abeler VM, et al (1993). Analysis of prognostic factors in stage I epithelial ovarian carcinoma: importance of degree of differentiation and deoxyribonucleic acid ploidy in predicting relapse. Am J Obstet Gynecol, 169, 40-52. DOI |
21 | Wang DS, Ren C, Qiu MZ, et al (2012). Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol, 33, 749-56. DOI |
22 | Yildirim MA, Seckin KD, Togrul C, et al (2014). Roles of neutrophil/lymphocyte and platelet/lymphocyte ratios in the early diagnosis of malignant ovarian masses. Asian Pac J Cancer Prev, 15, 6881-5. DOI |
![]() |